news - International Biopharmaceutical Industry

Current Edition

news

Emergex Awarded Innovate UK Grant to Progress its Universal and Pandemic Flu Vaccine

(‘Emergex’), a biotechnology company pioneering a new approach to vaccine development in the field of infectious diseases, today announces that Innovate UK, the UK’s ...

14 May 2018 news awarded | Emergex

Continue Reading →

news

J&J’s Janssen to Acquire BeneVir for $1 Billion

Janssen Biotech, part of Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson (J&J), announced on May 2, 2018 that it has entered into a defini...

11 May 2018 news 1Billion | Aquisition

Continue Reading →

news

Trade Idea: Biopharmaceutical Endocyte Hits 4-Year High on Earnings

With a market capitalization of just under $800 million, Indiana-based biopharmaceutical firm Endocyte (ECYT) Trade repo...

11 May 2018 news 4 | biopharmaceutical

Continue Reading →

news

Merck, Moderna Expand mRNA Cancer Vaccines Partnership

On May 3, 2018, Merck and Moderna Therapeutics, a biotechnology company focused on messenger RNA (mRNA) drug discovery and drug development, announced an expansion of...

11 May 2018 news Expand | Merck

Continue Reading →

news

Biopharmaceuticals Market Strongly guided by Companies like ABBVIE, AMGEN, BRISTOL

The market is expected to register a CAGR of 8.5% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological adva...

11 May 2018 news ABBVIE | biopharmaceutical

Continue Reading →

news

Putting the Technicals Into Perspective For Sino Biopharmaceutical ADR (SBHMY)

Investors have placed Sino Biopharmaceutical ADR (SBHMY) shares on watch as the Aroon Up indicator has moved above 70, indicating that there is strong upward momentum...

11 May 2018 news ADR | biopharmaceutical

Continue Reading →

news

Takeda to Acquire Shire for $62 Billion

Takeda Pharmaceutical Company Limited announced on May 8, 2018 that it has reached agreement on the terms of an offer to acquire Shire plc in a deal valued at $62 bil...

11 May 2018 news 62 | Acquire

Continue Reading →

news

Lilly strikes $1.6B deal to buy I-O player Armo Biosciences

Eli Lilly and Co. said it will buy Armo Biosciences Inc. for about $1.6 billion, in an all-cash transaction intended to bolster its immuno-oncology program through th...

11 May 2018 news 1.6B | Armo

Continue Reading →

news

Fully Supporting Customer Needs for Biologics Development and Manufacturing

Over the past seven years, Samsung BioLogics has constructed three state-of-the-art production facilities offering end-to-end integrated services to support the rapid...

8 May 2018 news biologics | development

Continue Reading →

news

Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development

Abcam, a global leader in the supply of life science research tools, today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the dev...

8 May 2018 news Abcam | alliance

Continue Reading →